SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-281111
Filing Date
2015-08-06
Accepted
2015-08-06 16:28:20
Documents
13
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d97339d10q.htm 10-Q 615375
2 EX-10.1 d97339dex101.htm EX-10.1 44673
3 EX-10.2 d97339dex102.htm EX-10.2 93840
4 EX-10.3 d97339dex103.htm EX-10.3 49175
5 EX-31.1 d97339dex311.htm EX-31.1 6262
6 EX-31.2 d97339dex312.htm EX-31.2 6195
7 EX-32.1 d97339dex321.htm EX-32.1 3858
  Complete submission text file 0001193125-15-281111.txt   3705360

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT alxa-20150630.xml EX-101.INS 578768
9 XBRL TAXONOMY EXTENSION SCHEMA alxa-20150630.xsd EX-101.SCH 42731
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxa-20150630_cal.xml EX-101.CAL 57647
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxa-20150630_def.xml EX-101.DEF 133736
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxa-20150630_lab.xml EX-101.LAB 354216
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxa-20150630_pre.xml EX-101.PRE 247967
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 151033540
SIC: 2834 Pharmaceutical Preparations